Mannatech, Incorporated (MTEX)
NASDAQ: MTEX · IEX Real-Time Price · USD
7.00
0.00 (-0.05%)
At close: Jul 2, 2024, 4:00 PM
6.99
-0.01 (-0.09%)
After-hours: Jul 2, 2024, 4:28 PM EDT
Company Description
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products.
It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.
Mannatech, Incorporated
| Country | United States |
| Founded | 1993 |
| IPO Date | Feb 16, 1999 |
| Industry | Food Distribution |
| Sector | Consumer Staples |
| Employees | 213 |
| CEO | Landen Granvel Fredrick |
Contact Details
Address: 1410 Lakeside Parkway, Suite 200 Flower Mound, Texas 75028 United States | |
| Phone | (972) 471-7400 |
| Website | mannatech.com |
Stock Details
| Ticker Symbol | MTEX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001056358 |
| CUSIP Number | 563771203 |
| ISIN Number | US5637712036 |
| Employer ID | 75-2508900 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Landen Granvel Fredrick | President, Chief Operating Officer, Chief Executive Officer and Chief Financial Officer |
| Erin Kemmler Barta | General Counsel and Corporate Secretary |
| Steven Lee Elder | Senior Vice President of Sales and Marketing |
| Dr. Steve Nugent | Chief Science and Health Officer and Chairman of Scientific Advisory Board |
| Diane Barton | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 2, 2024 | 8-K | Current Report |
| Jun 14, 2024 | 8-K | Current Report |
| May 14, 2024 | 8-K | Current Report |
| May 14, 2024 | 10-Q | Quarterly Report |
| Apr 29, 2024 | 8-K | Current Report |
| Apr 23, 2024 | ARS | Filing |
| Apr 23, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 23, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 28, 2024 | 10-K | Annual Report |
| Mar 28, 2024 | 8-K | Current Report |